
Shantell Laketa Heiber
Examiner (ID: 4200, Phone: (571)272-0886 , Office: P/2641 )
| Most Active Art Unit | 2645 |
| Art Unit(s) | 2641, 2644, 2645, 2617 |
| Total Applications | 943 |
| Issued Applications | 655 |
| Pending Applications | 110 |
| Abandoned Applications | 212 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7317472
[patent_doc_number] => 20040224305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Chimeric human papillomavirus (HPV) L1 molecules and uses therefor'
[patent_app_type] => new
[patent_app_number] => 09/876256
[patent_app_country] => US
[patent_app_date] => 2001-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12402
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224305.pdf
[firstpage_image] =>[orig_patent_app_number] => 09876256
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/876256 | Chimeric human papillomavirus (HPV) L1 molecules and uses therefor | Jun 7, 2001 | Issued |
Array
(
[id] => 7169417
[patent_doc_number] => 20050202413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use'
[patent_app_type] => utility
[patent_app_number] => 09/874140
[patent_app_country] => US
[patent_app_date] => 2001-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4358
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202413.pdf
[firstpage_image] =>[orig_patent_app_number] => 09874140
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/874140 | Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use | Jun 5, 2001 | Issued |
Array
(
[id] => 1316424
[patent_doc_number] => 06605284
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-08-12
[patent_title] => 'Gene coding for the measles virus mutant antigen'
[patent_app_type] => B2
[patent_app_number] => 09/873233
[patent_app_country] => US
[patent_app_date] => 2001-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15465
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/605/06605284.pdf
[firstpage_image] =>[orig_patent_app_number] => 09873233
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/873233 | Gene coding for the measles virus mutant antigen | Jun 4, 2001 | Issued |
Array
(
[id] => 6921398
[patent_doc_number] => 20010028883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-11
[patent_title] => 'Papillomavirus cellular receptor'
[patent_app_type] => new
[patent_app_number] => 09/874506
[patent_app_country] => US
[patent_app_date] => 2001-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3853
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20010028883.pdf
[firstpage_image] =>[orig_patent_app_number] => 09874506
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/874506 | Papillomavirus cellular receptor | Jun 4, 2001 | Abandoned |
Array
(
[id] => 6882641
[patent_doc_number] => 20010049113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-06
[patent_title] => 'Diagnosis and treatment of herpes infections'
[patent_app_type] => new
[patent_app_number] => 09/681740
[patent_app_country] => US
[patent_app_date] => 2001-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12501
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20010049113.pdf
[firstpage_image] =>[orig_patent_app_number] => 09681740
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/681740 | Diagnosis and treatment of herpes infections | May 29, 2001 | Abandoned |
Array
(
[id] => 6402986
[patent_doc_number] => 20020037285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Anti-CCR2 antibodies and methods of use therefor'
[patent_app_type] => new
[patent_app_number] => 09/866970
[patent_app_country] => US
[patent_app_date] => 2001-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15950
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20020037285.pdf
[firstpage_image] =>[orig_patent_app_number] => 09866970
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/866970 | Anti-CCR2 antibodies and methods of use therefor | May 28, 2001 | Issued |
Array
(
[id] => 1420887
[patent_doc_number] => 06503513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-01-07
[patent_title] => 'Diagnostics and therapy of diseases associated with HHV-8 infections'
[patent_app_type] => B2
[patent_app_number] => 09/860276
[patent_app_country] => US
[patent_app_date] => 2001-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 6477
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/503/06503513.pdf
[firstpage_image] =>[orig_patent_app_number] => 09860276
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/860276 | Diagnostics and therapy of diseases associated with HHV-8 infections | May 15, 2001 | Issued |
Array
(
[id] => 1392318
[patent_doc_number] => 06541253
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-04-01
[patent_title] => 'Diagnostics and therapy of diseases associated with HHV-8 infections'
[patent_app_type] => B2
[patent_app_number] => 09/860395
[patent_app_country] => US
[patent_app_date] => 2001-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 6480
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/541/06541253.pdf
[firstpage_image] =>[orig_patent_app_number] => 09860395
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/860395 | Diagnostics and therapy of diseases associated with HHV-8 infections | May 15, 2001 | Issued |
Array
(
[id] => 1296841
[patent_doc_number] => 06627418
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-30
[patent_title] => 'Detection of human herpes virus 6 (HHV6)'
[patent_app_type] => B1
[patent_app_number] => 09/787628
[patent_app_country] => US
[patent_app_date] => 2001-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6208
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/627/06627418.pdf
[firstpage_image] =>[orig_patent_app_number] => 09787628
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/787628 | Detection of human herpes virus 6 (HHV6) | May 14, 2001 | Issued |
Array
(
[id] => 987980
[patent_doc_number] => 06921535
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-26
[patent_title] => 'Attenuated Bovine Respiratory Syncytial virus'
[patent_app_type] => utility
[patent_app_number] => 10/312232
[patent_app_country] => US
[patent_app_date] => 2001-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8988
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/921/06921535.pdf
[firstpage_image] =>[orig_patent_app_number] => 10312232
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/312232 | Attenuated Bovine Respiratory Syncytial virus | May 1, 2001 | Issued |
Array
(
[id] => 7092872
[patent_doc_number] => 20010034022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-25
[patent_title] => 'Mixed cell diagnostic systems'
[patent_app_type] => new
[patent_app_number] => 09/847156
[patent_app_country] => US
[patent_app_date] => 2001-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19170
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20010034022.pdf
[firstpage_image] =>[orig_patent_app_number] => 09847156
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/847156 | Mixed cell diagnostic systems | Apr 30, 2001 | Issued |
Array
(
[id] => 6986796
[patent_doc_number] => 20010036628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-01
[patent_title] => 'Mixed cell diagnostic systems'
[patent_app_type] => new
[patent_app_number] => 09/847006
[patent_app_country] => US
[patent_app_date] => 2001-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19171
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20010036628.pdf
[firstpage_image] =>[orig_patent_app_number] => 09847006
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/847006 | Mixed cell diagnostic systems | Apr 30, 2001 | Abandoned |
| 09/743020 | Peptides for inhibiting hpv e7 proteins | Apr 29, 2001 | Abandoned |
Array
(
[id] => 7093035
[patent_doc_number] => 20010034054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-25
[patent_title] => 'Materials and methods for simplified AAV production'
[patent_app_type] => new
[patent_app_number] => 09/841768
[patent_app_country] => US
[patent_app_date] => 2001-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7348
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20010034054.pdf
[firstpage_image] =>[orig_patent_app_number] => 09841768
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/841768 | Materials and methods for simplified AAV production | Apr 23, 2001 | Abandoned |
Array
(
[id] => 1477332
[patent_doc_number] => 06344314
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-02-05
[patent_title] => 'Determined DNA sequenced derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions'
[patent_app_type] => B2
[patent_app_number] => 09/832852
[patent_app_country] => US
[patent_app_date] => 2001-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 5045
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/344/06344314.pdf
[firstpage_image] =>[orig_patent_app_number] => 09832852
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/832852 | Determined DNA sequenced derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions | Apr 11, 2001 | Issued |
Array
(
[id] => 1176560
[patent_doc_number] => 06743593
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-01
[patent_title] => 'Immunological methodology for discerning human papillomavirus'
[patent_app_type] => B2
[patent_app_number] => 09/828645
[patent_app_country] => US
[patent_app_date] => 2001-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 0
[patent_no_of_words] => 5296
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/743/06743593.pdf
[firstpage_image] =>[orig_patent_app_number] => 09828645
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/828645 | Immunological methodology for discerning human papillomavirus | Apr 4, 2001 | Issued |
Array
(
[id] => 1272258
[patent_doc_number] => 06649167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-11-18
[patent_title] => 'Papillomavirus truncated L1 protein and fusion protein constructs'
[patent_app_type] => B2
[patent_app_number] => 09/824017
[patent_app_country] => US
[patent_app_date] => 2001-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8992
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/649/06649167.pdf
[firstpage_image] =>[orig_patent_app_number] => 09824017
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/824017 | Papillomavirus truncated L1 protein and fusion protein constructs | Apr 2, 2001 | Issued |
Array
(
[id] => 6323980
[patent_doc_number] => 20020197264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Protecting against canine oral papillomavirus (COPV)'
[patent_app_type] => new
[patent_app_number] => 09/822662
[patent_app_country] => US
[patent_app_date] => 2001-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18976
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20020197264.pdf
[firstpage_image] =>[orig_patent_app_number] => 09822662
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/822662 | Protecting against canine oral papillomavirus (COPV) | Apr 1, 2001 | Abandoned |
Array
(
[id] => 5814257
[patent_doc_number] => 20020039584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-04
[patent_title] => 'Papilloma virus capsomere vaccine formulations and methods of use'
[patent_app_type] => new
[patent_app_number] => 09/820765
[patent_app_country] => US
[patent_app_date] => 2001-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7646
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20020039584.pdf
[firstpage_image] =>[orig_patent_app_number] => 09820765
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/820765 | Papilloma virus capsomere vaccine formulations and methods of use | Mar 29, 2001 | Abandoned |
Array
(
[id] => 1523219
[patent_doc_number] => 06352696
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-05
[patent_title] => 'Papillomavirus truncated L1 protein and fusion protein constructs'
[patent_app_type] => B1
[patent_app_number] => 09/820764
[patent_app_country] => US
[patent_app_date] => 2001-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10478
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/352/06352696.pdf
[firstpage_image] =>[orig_patent_app_number] => 09820764
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/820764 | Papillomavirus truncated L1 protein and fusion protein constructs | Mar 29, 2001 | Issued |